Terumo targets bioresorbable heart stent market with ART deal
This article was originally published in Clinica
Executive Summary
Japanese cardiovascular device maker Terumo has struck a deal with French stent specialist Arterial Remodeling Technologies to invest in the development of a drug-eluting bioresorbable heart stent. The agreement also gives Terumo the exclusive option to buy out ART at any time before initiating clinical trials of the stent.